Cargando…

Serum Cytokeratin-18 Is Associated with NOX2-Generated Oxidative Stress in Patients with Nonalcoholic Fatty Liver

Background & Aims. Hepatocyte apoptosis may play a role in progression of nonalcoholic fatty liver and oxidative stress seems one of the key mechanisms responsible for liver damage. The aim was to determine the association of oxidative stress with cytokeratin-18 M30 fragment levels, a marker of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Del Ben, M., Polimeni, L., Baratta, F., Bartimoccia, S., Carnevale, R., Loffredo, L., Pignatelli, P., Violi, F., Angelico, F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3941779/ https://www.ncbi.nlm.nih.gov/pubmed/24678423 http://dx.doi.org/10.1155/2014/784985

Ejemplares similares

NOX2-generated oxidative stress is associated with severity of ultrasound liver steatosis in patients with non-alcoholic fatty liver disease
por: Del Ben, Maria, et al.
Publicado: (2014)

Moderate Weight Loss Decreases Oxidative Stress and Increases Antioxidant Status in Patients with Metabolic Syndrome
por: Del Ben, Maria, et al.
Publicado: (2012)

High Compliance to Mediterranean Diet Associates with Lower Platelet Activation and Liver Collagen Deposition in Patients with Nonalcoholic Fatty Liver Disease
por: Baratta, Francesco, et al.
Publicado: (2022)

Poor Adherence to Mediterranean Diet and Serum Lipopolysaccharide Are Associated with Oxidative Stress in Patients with Non-Alcoholic Fatty Liver Disease
por: Baratta, Francesco, et al.
Publicado: (2020)

Extra virgin olive oil use is associated with improved post-prandial blood glucose and LDL cholesterol in healthy subjects
por: Violi, F, et al.
Publicado: (2015)

Relationship Between Platelet and Urinary 8‐Iso‐PGF2α Levels in Subjects With Different Degrees of NOX2 Regulation
por: Carnevale, Roberto, et al.
Publicado: (2013)

Extra Virgin Olive Oil Reduces Gut Permeability and Metabolic Endotoxemia in Diabetic Patients
por: Bartimoccia, Simona, et al.
Publicado: (2022)

Nonalcoholic Fatty Liver Disease and the Kidney: A Review
por: Umbro, Ilaria, et al.
Publicado: (2021)

Similar Reduction of Cholesterol-Adjusted Vitamin E Serum Levels in Simple Steatosis and Non-Alcoholic Steatohepatitis
por: Pastori, Daniele, et al.
Publicado: (2015)

Does Lysosomial Acid Lipase Reduction Play a Role in Adult Non-Alcoholic Fatty Liver Disease?
por: Baratta, Francesco, et al.
Publicado: (2015)

Oxidative stress mediated arterial dysfunction in patients with obstructive sleep apnoea and the effect of continuous positive airway pressure treatment
por: Del Ben, Maria, et al.
Publicado: (2012)

Oxidative stress mediated platelet activation in patients with congenital analbuminemia: Effect of albumin infusion
por: Baratta, Francesco, et al.
Publicado: (2021)

Association of liver biomarkers and cytokeratin-18 in Nonalcoholic fatty liver disease patients
por: Altaf, Benash, et al.
Publicado: (2020)

PCSK9 Regulates Nox2-Mediated Platelet Activation via CD36 Receptor in Patients with Atrial Fibrillation
por: Cammisotto, Vittoria, et al.
Publicado: (2020)

Structure, Activation, and Regulation of NOX2: At the Crossroad between the Innate Immunity and Oxidative Stress-Mediated Pathologies
por: Nocella, Cristina, et al.
Publicado: (2023)

The Sodium–Glucose Co-Transporter-2 (SGLT2) Inhibitors Reduce Platelet Activation and Thrombus Formation by Lowering NOX2-Related Oxidative Stress: A Pilot Study
por: Pignatelli, Pasquale, et al.
Publicado: (2022)

Reduced Lysosomal Acid Lipase Activity in Adult Patients With Non-alcoholic Fatty Liver Disease
por: Baratta, Francesco, et al.
Publicado: (2015)

PNPLA3 variant and portal/periportal histological pattern in patients with biopsy-proven non-alcoholic fatty liver disease: a possible role for oxidative stress
por: Carpino, Guido, et al.
Publicado: (2017)

Epicatechin and Catechin Modulate Endothelial Activation Induced by Platelets of Patients with Peripheral Artery Disease
por: Carnevale, R., et al.
Publicado: (2014)

Gut-derived low-grade endotoxaemia, atherothrombosis and cardiovascular disease
por: Violi, Francesco, et al.
Publicado: (2022)

Remnant Lipoprotein Cholesterol and Cardiovascular and Cerebrovascular Events in Patients with Non-Alcoholic Fatty Liver Disease
por: Pastori, Daniele, et al.
Publicado: (2018)

Relationship between Serum Cytokeratin-18, Control Attenuation Parameter, NAFLD Fibrosis Score, and Liver Steatosis in Nonalcoholic Fatty Liver Disease
por: Kosasih, Sumitro, et al.
Publicado: (2018)

Age-related increase of thromboxane B(2) and risk of cardiovascular disease in atrial fibrillation
por: Pastori, Daniele, et al.
Publicado: (2016)

Vitamin E Serum Levels and Bleeding Risk in Patients Receiving Oral Anticoagulant Therapy: a Retrospective Cohort Study
por: Pastori, Daniele, et al.
Publicado: (2013)

Non-alcoholic fatty liver disease (NAFLD), metabolic syndrome and cardiovascular events in atrial fibrillation. A prospective multicenter cohort study
por: Pastori, Daniele, et al.
Publicado: (2021)

Dark Chocolate Acutely Improves Walking Autonomy in Patients With Peripheral Artery Disease
por: Loffredo, Lorenzo, et al.
Publicado: (2014)

Overexpression of the Vitronectin V10 Subunit in Patients with Nonalcoholic Steatohepatitis: Implications for Noninvasive Diagnosis of NASH
por: Del Ben, Maria, et al.
Publicado: (2018)

SARS-CoV-2 and myocardial injury: a role for Nox2?
por: Violi, Francesco, et al.
Publicado: (2020)

Underuse of oral anticoagulants in patients with nonvalvular atrial fibrillation in Italy
por: Ferro, D., et al.
Publicado: (2007)

Cytokeratin 18, Alanine Aminotransferase, Platelets and Triglycerides Predict the Presence of Nonalcoholic Steatohepatitis
por: Cao, Wei, et al.
Publicado: (2013)

Complementary Role of Fibroblast Growth Factor 21 and Cytokeratin 18 in Monitoring the Different Stages of Nonalcoholic Fatty Liver Disease
por: Wu, Guangyu, et al.
Publicado: (2017)

Reduced lysosomal acid lipase activity: A new marker of liver disease severity across the clinical continuum of non-alcoholic fatty liver disease?
por: Baratta, Francesco, et al.
Publicado: (2019)

Reduced Lysosomal Acid Lipase Activity in Blood and Platelets Is Associated With Nonalcoholic Fatty Liver Disease
por: Ferri, Flaminia, et al.
Publicado: (2020)

Nox2 activation in Covid-19
por: Violi, Francesco, et al.
Publicado: (2020)

Screening for nonalcoholic steatohepatitis by using cytokeratin 18 and transient elastography in HIV mono-infection
por: Benmassaoud, Amine, et al.
Publicado: (2018)

Cytokeratin-18 and uric acid predicts disease severity in Taiwanese nonalcoholic steatohepatitis patients
por: Huang, Jee-Fu, et al.
Publicado: (2017)

Serum Cytokeratin-18 Levels for Liver Fibrosis Prediction
por: Caviglia, Gian Paolo, et al.
Publicado: (2015)

A new detection system for serum fragmented cytokeratin 18 as a biomarker reflecting histologic activities of human nonalcoholic steatohepatitis
por: Eguchi, Akiko, et al.
Publicado: (2022)

Serum Level of Cytokeratin 18 (M65) as a Prognostic Marker of High Cardiovascular Disease Risk in Individuals with Non-Alcoholic Fatty Liver Disease
por: Pagano, Sabrina, et al.
Publicado: (2023)

Oxidative Stress and Gut-Derived Lipopolysaccharides in Neurodegenerative Disease: Role of NOX2
por: Loffredo, Lorenzo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tkqd24hei1tjn44k8k8do7d5qm